"Given the safety profile, based on treatment of 1600 patients, what does one have to lose by prescribing or taking LL? Can LL serve as preventative medicine? Can it be administered at the earliest onset of disease or trauma in order to reduce inflammation and promote improved efficacy of other treatment modalities?"

I said it several times before, and it is always worth repeating; Leronlimab should be stocked in every emergency facility in the United States (civilian and military). Then, we should look at the global market. We just need one approval to get this started! GLTUA